About Prudent Bio
Prudent Bio is a Healthcare company based in Bridgewater (United States) founded in 2024. It develops lower-cost biopharmaceutical therapies through research and partnerships. It operates on a B2B and Partnership-based model. Its Indian entity Prudentbio Research Private Limited reported revenue of ₹10.8 Lakh. Prudent Bio offers products and services including Biosimilar Therapies and Therapy Pipeline. Its focus areas include Biopharmaceuticals, Therapeutics, Global Partnerships and Biosimilars. Similar companies include Biogen, ADMA Biologics, Kymeratx, BioNTech and Generate Biomedicines and 5 more; 9 of its 10 listed similar companies have raised funding.
Company details
Prudent Bio is a biopharmaceutical company focused on creating affordable therapies to improve global healthcare access. It achieves this by developing biosimilars and exploring partnerships, including licensing deals and strategic alliances. Based in Bridgewater, New Jersey, USA, the company aims to benefit patients through innovative pipelines and shared-profit ventures. Its activities emphasize cost reduction in therapeutics without compromising quality.
- Headquarters Bridgewater, United States
- SectorsHealthcare
- Website prudentbio.com
- Legal Name Prudentbio Research Private Limited
- Date of Incorporation 22 May, 2018
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹10.8 Lakh
FY 2025 · -13% YoY
- Net Loss-₹2 Lakh
FY 2025 · -19% margin
- EBITDA-₹2 Lakh
FY 2025 · -19% margin
Associated legal entities of Prudent Bio
Prudent Bio operates through Prudentbio Research Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Prudentbio Research Private Limited CIN U73100KA2018PTC113339 | Active | 22 May 2018 | Bangalore, Karnataka | ₹0.1 Cr | – | 2 | View details |
Products & Services of Prudent Bio
Prudent Bio offers a comprehensive portfolio of products and services, including Biosimilar Therapies and Therapy Pipeline.
Develops lower-cost alternatives to biologic drugs for global markets.
Innovative pipeline for affordable healthcare solutions worldwide.
Board of directors of Prudentbio Research Private Limited (Prudent Bio)
Prudentbio Research Private Limited is the primary company behind Prudent Bio. The board of Prudentbio Research Private Limited currently have 2 directors; the longest-serving is Sagar Shashidhar Manoli, appointed in 2019. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sagar Shashidhar Manoli DIN 08528812 | Additional Director | 29 Jul 2019 | 7 yrs 2 mo | Prudentbio Research Private Limited |
| Shivalingappa Mahalingappa Gowda DIN 09627530 | Additional Director | 18 May 2022 | 4 yrs 5 mo | Prudentbio Research Private Limited |
Financials of Prudent Bio
Figures of Prudentbio Research Private Limited, the primary company behind Prudent Bio, for FY 2025. Revenue was ₹10.8 Lakh (-13% year on year). Net loss was -₹2 Lakh (-19% margin). EBITDA was -₹2 Lakh (-19% margin). Revenue has grown at a compounded annual rate of +70% over three years.
- ₹10.8 LakhRevenue · FY 2025 · -13% YoY
- -₹2 LakhNet loss · -19% margin
- -₹2 LakhEBITDA · -19% margin
- ₹1 LakhPaid-up capital
- +70%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Prudentbio Research Private Limited are on its company page.
Detailed financial statements for Prudent Bio
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Prudent Bio
Prudent Bio has 10 listed similar companies in our database, 9 of them funded. They include Biogen, ADMA Biologics, Kymeratx, BioNTech and Generate Biomedicines, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| biogen.com | 1978 | Cambridge, United States | $80M | 1 | Therapies for neurodegenerative and immunology disorders are developed. | |
| admabiologics.com | 2005 | Ramsey, United States | $17.55M | 498 | Plasma-based biologics are developed for immune deficiency and infectious diseases. | |
| kymeratx.com | 2016 | Cambridge, United States | $197M | 150 | Small molecule protein degraders are developed for various disorders. | |
| biontech.com | 2008 | Mainz, Germany | $805.99M | 4,530 | Immunotherapeutics for cancer and other diseases are developed. | |
| generatebiomedicines.com | 2018 | Somerville, United States | $643M | 286 | Developer of novel protein-based therapeutics using machine learning and biological engineering | |
| puretechhealth.com | 2001 | Boston, United States | $107M | 171 | Immunotherapeutics are developed for inflammation, fibrosis, and lung diseases. | |
| ucb.com | 1928 | Brussels, Belgium | – | 79 | Therapies for immunological and neurological disorders are developed. | |
| veratx.com | 2016 | San Francisco, United States | $196.58M | 46 | Therapeutic solutions for immunological and inflammatory diseases are developed. | |
| cabalettabio.com | 2017 | Radnor, United States | $88.26M | 60 | Developer of CAAR T cells for B cell-mediated autoimmune diseases | |
| apogeetherapeutics.com | 2022 | Waltham, United States | $149M | 91 | Developer of therapeutics for immunological and inflammatory disorders |
Detailed similar companies of Prudent Bio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Prudent Bio (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Prudent Bio
Prudent Bio was founded in 2024.
Prudent Bio is headquartered in Bridgewater, United States. It is registered at Bridgewater, New Jersey, United States.
The primary company behind Prudent Bio, Prudentbio Research Private Limited, reported revenue of ₹10.8 Lakh for FY 2025, down 13% year on year.
Prudent Bio is a biopharmaceutical company focused on creating affordable therapies to improve global healthcare access. It achieves this by developing biosimilars and exploring partnerships, including licensing deals and strategic alliances. Based in Bridgewater, New Jersey, USA, the company aims to benefit patients through innovative pipelines and shared-profit ventures. Its activities emphasize cost reduction in therapeutics without compromising quality.
Prudent Bio's top competitors include ADMA Biologics, BioNTech and Vera Therapeutics.
Prudent Bio offers Biosimilar Therapies and Therapy Pipeline.
Prudent Bio operates through Prudentbio Research Private Limited.
The legal entities of Prudent Bio currently have 2 directors, including Shivalingappa Mahalingappa Gowda, Sagar Shashidhar Manoli.